Functional definition of the mutation cluster region of adenomatous polyposis coli in colorectal tumours

被引:47
作者
Kohler, Eva Maria [1 ]
Derungs, Adrian [1 ,2 ]
Daum, Gabriele [1 ]
Behrens, Juergen [1 ]
Schneikert, Jean [1 ]
机构
[1] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, D-91054 Erlangen, Germany
[2] Cantonal Hosp St Gallen, Dept Internal Med, CH-9007 St Gallen, Switzerland
关键词
D O I
10.1093/hmg/ddn095
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mutation cluster region (MCR) of adenomatous polyposis coli (APC) is located within the central part of the open reading frame, overlapping with the region encoding the 20 amino acid repeats (20R) that are beta-catenin-binding sites. Each mutation in the MCR leads to the synthesis of a truncated APC product expressed in a colorectal tumour. The MCR extends from the 3' border of the first 20R coding region to approximately the middle of the third 20R coding region, reflecting both positive and negative selections of the N- and C-terminal halves of the APC protein in colon cancer cells, respectively. In contrast, the second 20R escapes selection and can be either included or excluded from the truncated APC products found in colon cancer cells. To specify the functional outcome of the selection of the mutations, we investigated the beta-catenin binding capacity of the first three 20R in N-terminal APC fragments. We found in co-immunoprecipitation and intracellular co-localization experiments that the second 20R is lacking any beta-catenin binding activity. Similarly, we also show that the tumour-associated truncations abolish the interaction of beta-catenin with the third 20R. Thus, our data provide a functional definition of the MCR: the APC fragments typical of colon cancer are selected for the presence of a single functional 20R, the first one, and are therefore equivalent relative to beta-catenin binding.
引用
收藏
页码:1978 / 1987
页数:10
相关论文
共 51 条
[1]   The 'just-right' signaling model:: APC somatic mutations are selected based on a specific level of activation of the β-catenin signaling cascade [J].
Albuquerque, C ;
Breukel, C ;
van der Luijt, R ;
Fidalgo, P ;
Lage, P ;
Slors, FJM ;
Leitao, CN ;
Fodde, R ;
Smits, R .
HUMAN MOLECULAR GENETICS, 2002, 11 (13) :1549-1560
[2]   Functional interaction of an axin homolog, conductin, with β-catenin, APC, and GSK3β [J].
Behrens, J ;
Jerchow, BA ;
Würtele, M ;
Grimm, J ;
Asbrand, C ;
Wirtz, R ;
Kühl, M ;
Wedlich, D ;
Birchmeier, W .
SCIENCE, 1998, 280 (5363) :596-599
[3]   The Wnt connection to tumorigenesis [J].
Behrens, J ;
Lustig, B .
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY, 2004, 48 (5-6) :477-487
[4]   APC gene: Database of germline and somatic mutations in human tumors and cell lines [J].
Beroud, C ;
Soussi, T .
NUCLEIC ACIDS RESEARCH, 1996, 24 (01) :121-124
[5]   EphB/EphrinB receptors and Wnt signaling in colorectal cancer [J].
Clevers, H ;
Batlle, E .
CANCER RESEARCH, 2006, 66 (01) :2-5
[6]   Refining the relation between 'first hits' and 'second hits' at the APC locus:: the 'loose fit' model and evidence for differences in somatic mutation spectra among patients [J].
Crabtree, M ;
Sieber, OM ;
Lipton, L ;
Hodgson, SV ;
Lamlum, H ;
Thomas, HJW ;
Neale, K ;
Phillips, RKS ;
Heinimann, K ;
Tomlinson, IPM .
ONCOGENE, 2003, 22 (27) :4257-4265
[7]   WNT signaling in the normal intestine and colorectal cancer [J].
de Lau, Wim ;
Barker, Nick ;
Clevers, Hans .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 :471-491
[8]  
Dihlmann S, 1999, CANCER RES, V59, P1857
[9]  
EKLOF SK, 2001, EMBO J, V20, P6203
[10]   The ABC of APC [J].
Fearnhead, NS ;
Britton, MP ;
Bodmer, WF .
HUMAN MOLECULAR GENETICS, 2001, 10 (07) :721-733